6. Monsanto (MON - Get Report), along with its subsidiaries, is a provider of agricultural products for farmers. Its seeds, biotechnology trait products and herbicides provide farmers with solutions that improve productivity and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity.
During the second quarter of 2011, the company reported earnings of $1 billion, or $1.88 per share, compared to $887 million, or $1.60 per share in the year-ago quarter. Revenue for the period increased 6.1% year-over-year to $4.1 billion from $3.9 billion led by a 5.3% and 10.3% increase in revenue from seeds and genomics, and the agricultural productivity segment, respectively.
During April, the company paid a quarterly dividend of 28 cents per share. The company expects to generate strong cash flow in the future, and remains committed to returning value to shareowners through vehicles such as investments that expand the business, dividends and share repurchases.Of the 24 analysts covering the stock, 46% recommend it as a buy, while 46% rate it a hold. On average, analysts estimate 17.5% upside, to $77.07 in value from current levels.